NCT04183166TG4050Mayo ClinicHNSCCSouth Central - Oxford
…Background In the phase I trial TG4050.02 ( NCT04183166) evaluating TG4050 in resected, locally advanced HNSCC patients…
5,089articles mentioning funders
9,137funder mentions
3,238distinct funders extracted
0%of mentions human-reviewed
All extracted funders
Showing 1,561–1,620 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
InnoHK Initiative1Innovation Fund of the Federal Joint Committee of Germany1Innovation and Technology Fund1Instiglio1Institute for Safe Medication Practices1Institute of Medicine1Institutional Animal Care and Use Committee1Institutional Ethical Review Committee1Institutional Research Ethics Committee1Integrated Public Use Microdata Series1Intensive Care Society1Inter-American Development Bank1Internal Medicine Service1Internal funding1International Association for Trauma Surgery and Intensive Care1International Association of Diabetes and Pregnancy Study Groups1International Cancer Benchmarking Partnership1International Cartilage Regeneration & Joint Preservation Society1International Clinical Trial Registry Platform1International Clinical Trials Registry Platform1International Council for Harmonisation1International Development Association1International Developmental Pediatrics Association1International Federation of Clinical Chemistry and Laboratory Medicine1International Federation of Red Cross and Red Crescent Societies1International Federation of Sports Physical Therapy1International Holocaust Remembrance Alliance1International Labour Organisation1International Medical Device Regulators1International Organisation for Standardisation1International Organization for Migration1International Organization for Standardization1International Paediatric Stroke Organization Executive Committee1International Parkinson and Movement Disorders Society1International Pediatric Association1International Pharmaceutical Abstracts1International Pharmaceutical Federation1International Prehabilitation and Perioperative Exercise Testing Society1International Radiosurgery Research Foundation1International Rescue Committee1International Tobacco Control Four Country Smoking and Vaping Survey1Iovance Biotherapeutics1Iran Health Insurance Organization1Italian Society of Infectious and Tropical Diseases1JAMA 20251JAMA Intern Med 20251JAMA Network1JEP-2025-6251JGSDF1JGW Patterson Foundation1JIPMER Institutional Ethics Committee1JMDC Inc1JNJ Medtech1JP Morgan1James Lind Alliance Priority Setting Partnership1Jaminan Kesehatan Nasional1Japan Agency for Medical Research and Development1Japanese Long-Term Care Insurance system1Jazz Pharmaceuticals1Joint British Diabetes Societies1
Articles mentioning funders
5,089 articles · page 330 of 425NCT04162015nivolumabDiffuse pleural mesotheliomapemetrexedcisplatincarboplatinplatinumP/D
…exed prior to P/D (2 cycles) for patients with resectable DPM ( NCT04162015).Methods To comprehensively assess tumor and immune microenviro…
Bristol-Myers Squibbneoadjuvant immunotherapynivolumabEGFR-mutant NSCLCchemotherapyCTONG1104
…and families involved in this study. This work was supported by Bristol-Myers Squibb, Guangdong Provincial Key Lab of Translational Medicine in Lung…
Foundation for the National Institutes of Health, Inc.CAN-2409docetaxelNSCLCsacituzumab govitecanvalacyclovir
…oject was made possible through funding support provided to the Foundation for the National Institutes of Health, Inc. (FNIH) by: AbbVie Inc., Amgen Inc., Boehringer-Ingelheim Pharma…
AstraZenecadurvalumabcapivasertibDurvaolaparibOlaCaprelapse/refractory solid cancers
…ing macrophages and stromal cells are underway.Acknowledgements AstraZeneca’s support is gratefully acknowledgedTrial Registration NCT03772…
Astellas Pharma Inc.ASP1012la/m solid tumorsadvanced solid tumorsOxford PharmaGenesis Inc.
…uding 3×10 9 pfu/dose.Acknowledgements This study was funded by Astellas Pharma Inc. Medical writing support, conducted in accordance with Good Publ…
IRB00115160cemiplimabEmory Universitymetastatic cutaneous squamous cell carcinoma (CSCC)
…proval The study was approved by the Emory IRB (approval number IRB00115160) and participants gave informed consent to take part in this st…
FDAMitazalimabmFOLFIRINOX
… Journal for ImmunoTherapy of Cancer 2024;12(Suppl 2):A677–A678.FDA. Optimizing the dose of human prescription drugs and biological…
FDAEVOLVE104EIU-104101urothelial carcinomasquamous cell carcinomasCohort BCohort AEVOLVE TCEstransitional cell carcinomas of the urinary tractlocally advanced or metastatic solid tumors
…g.Ethics Approval Study EIU-104101 is currently under review by FDA and will only begin enrollment upon clearance from relevant hea…
American Surgical Association Research AwardAppendiceal cancerMD Anderson Cancer CenterBarnes-Jewish HospitalpaclitaxelUniversity of Texas MD Anderson Cancer Centercolorectal cancerWashington University Institutional Review Board
…cy.Acknowledgements This work was supported by funding from the American Surgical Association Research Award (Dr. Beth A. Helmink), NIH grant R37AI049653 (Dr. Gwendalyn J. …
PHASE ONE FoundationECOG Performance StatusDana-Farber Cancer InstituteIL-12myeloid leukemiaIL-15IL-18PROCpembrolizumabDana-Farber/Harvard Cancer Center+6 more
…uable. The authors are deeply grateful for funding support from PHASE ONE Foundation and from Pan-Mass Challenge Team Ovarian Cancer.References Disi…
Mount Sinai PPHS IRBHNSCCimmunotherapyMount Sinai Institutional BiorepositoryHead and neck squamous cell carcinoma (HNSCC)
…drivers of immunotherapy resistance among HNSCC.Ethics Approval Mount Sinai PPHS IRB approved STUDY-21-01683…